Dr. Wu Skincare Co., Ltd. (6523.TWO)
TWD 151.0
(0.33%)
TWD 151.0
(0.33%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 535.45 Million TWD | 23.3% |
| 2022 | 434.3 Million TWD | 12.8% |
| 2021 | 385.02 Million TWD | -52.35% |
| 2020 | 807.97 Million TWD | 209.37% |
| 2019 | 261.17 Million TWD | 182.92% |
| 2018 | 92.31 Million TWD | -39.5% |
| 2017 | 152.58 Million TWD | -60.73% |
| 2016 | 388.59 Million TWD | 43.83% |
| 2015 | 270.16 Million TWD | 6.91% |
| 2014 | 252.69 Million TWD | 13.08% |
| 2013 | 223.46 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 93.9 Million TWD | -54.25% |
| 2024 Q1 | 205.32 Million TWD | 45.33% |
| 2023 Q3 | 155.39 Million TWD | 43.07% |
| 2023 Q1 | 134.21 Million TWD | 10.9% |
| 2023 Q2 | 108.61 Million TWD | -19.07% |
| 2023 FY | - TWD | 23.3% |
| 2023 Q4 | 137.28 Million TWD | -11.65% |
| 2022 Q2 | 73.64 Million TWD | -47.98% |
| 2022 Q1 | 141.57 Million TWD | 53.82% |
| 2022 Q4 | 121.01 Million TWD | 23.4% |
| 2022 Q3 | 98.07 Million TWD | 33.16% |
| 2022 FY | - TWD | 12.8% |
| 2021 FY | - TWD | -52.35% |
| 2021 Q1 | 108.63 Million TWD | -82.71% |
| 2021 Q4 | 92.03 Million TWD | -24.91% |
| 2021 Q3 | 122.56 Million TWD | 98.35% |
| 2021 Q2 | 61.79 Million TWD | -43.12% |
| 2020 Q2 | 21.99 Million TWD | -67.26% |
| 2020 Q4 | 628.46 Million TWD | 595.55% |
| 2020 FY | - TWD | 209.37% |
| 2020 Q3 | 90.35 Million TWD | 310.87% |
| 2020 Q1 | 67.17 Million TWD | -21.01% |
| 2019 Q2 | 42.42 Million TWD | -50.22% |
| 2019 Q3 | 48.46 Million TWD | 14.23% |
| 2019 FY | - TWD | 182.92% |
| 2019 Q1 | 85.22 Million TWD | 452.57% |
| 2019 Q4 | 85.04 Million TWD | 75.47% |
| 2018 Q4 | 15.42 Million TWD | -38.75% |
| 2018 Q3 | 25.18 Million TWD | 22.61% |
| 2018 Q2 | 20.54 Million TWD | -34.09% |
| 2018 Q1 | 31.16 Million TWD | 0.94% |
| 2018 FY | - TWD | -39.5% |
| 2017 Q4 | 30.87 Million TWD | 52.23% |
| 2017 Q3 | 20.28 Million TWD | 164.64% |
| 2017 Q2 | 7.66 Million TWD | -91.83% |
| 2017 FY | - TWD | -60.73% |
| 2017 Q1 | 93.76 Million TWD | -21.58% |
| 2016 Q2 | 90.59 Million TWD | 9.21% |
| 2016 FY | - TWD | 43.83% |
| 2016 Q4 | 119.56 Million TWD | 25.24% |
| 2016 Q3 | 95.47 Million TWD | 5.38% |
| 2016 Q1 | 82.95 Million TWD | -26.43% |
| 2015 Q2 | 29.84 Million TWD | -26.65% |
| 2015 FY | - TWD | 6.91% |
| 2015 Q3 | 86.87 Million TWD | 191.07% |
| 2015 Q1 | 40.69 Million TWD | -55.29% |
| 2015 Q4 | 112.75 Million TWD | 29.78% |
| 2014 Q1 | 36.15 Million TWD | 0.0% |
| 2014 Q2 | 36.15 Million TWD | 0.0% |
| 2014 FY | - TWD | 13.08% |
| 2014 Q4 | 91 Million TWD | 1.82% |
| 2014 Q3 | 89.38 Million TWD | 147.24% |
| 2013 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Mikobeaute International Co., Ltd. | 127.27 Million TWD | -320.722% |
| Shiny Brands Group Co., Ltd. | 536.02 Million TWD | 0.106% |
| Sea Mild Biotechnology Co., Ltd. | 19.31 Million TWD | -2671.803% |
| TCI Co., Ltd. | 1.87 Billion TWD | 71.376% |
| Fu Burg Industrial Co., Ltd. | -16.62 Million TWD | 3320.213% |
| Grand Hall Enterprise Co., Ltd. | 393.82 Million TWD | -35.964% |
| Tittot Company Limited | -18.92 Million TWD | 2929.513% |